Policy | February 2019

When President Donald Trump signed a federal funding bill into law on Feb. 15, it included text that said that all mammography providers must include updated information about breast density in reports sent to both patients and their physicians.

Joseph J. Cappello, executive director of Are You Dense and Are You Dense Advocacy, spoke to Radiology Business about how it felt to finally see federal breast density notification requirements signed into law.

Genetic testing should be available for all breast cancer patients to determine hereditary risk in addition to standard imaging exams, according to new guidelines published Feb. 14 by The American Society of Breast Surgeons. 

More consistent follow-up protocols after benign concordant MRI-guided percutaneous core needle biopsies (MR-PCNBs) could lead to better overall patient care, according to a case study published in the Journal of the American College of Radiology.

The FDA has published a new letter to providers in radiology, pathology, emergency medicine and several other specialties with updated information related to breast implant associated-anaplastic large cell lymphoma (BIA-ALCL).

The American College of Radiology (ACR) has asked radiologists and other healthcare professionals to send them invoices that reflect the real-world costs associated with purchasing ultrasound equipment.

The American Society of Radiologic Technologists (ASRT) has shown support for new licensure bills introduced in Missouri and Oklahoma.

The Medical Imaging & Technology Alliance (MITA) has released a new white paper outlining the differences between servicing and remanufacturing activities for medical imaging devices, urging the FDA to clarify its own definitions of the two terms.